Global HPV Testing Supply, Demand and Key Producers, 2026-2032
Description
The global HPV Testing market size is expected to reach $ 1782 million by 2032, rising at a market growth of 8.1% CAGR during the forecast period (2026-2032).
The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three sub-segments, namely, follow-up testing, co-testing, HPV primary testing.
Global HPV Testing key players include Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD, etc. Global top five players hold a share about 80%.
North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, having a total share about 45 percent.
In terms of product, Co-testing is the largest segment, with a share about 55%. And in terms of application, the largest application is Cervical Cancer Screening, followed by Vaginal Cancer Screening, etc.
This report studies the global HPV Testing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for HPV Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of HPV Testing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global HPV Testing total market, 2021-2032, (USD Million)
Global HPV Testing total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: HPV Testing total market, key domestic companies, and share, (USD Million)
Global HPV Testing revenue by player, revenue and market share 2021-2026, (USD Million)
Global HPV Testing total market by Type, CAGR, 2021-2032, (USD Million)
Global HPV Testing total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global HPV Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD, Seegene, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world HPV Testing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global HPV Testing Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global HPV Testing Market, Segmentation by Type:
HPV Testing
Follow-up HPV Testing
Co-testing
Global HPV Testing Market, Segmentation by Application:
Cervical Cancer Screening
Vaginal Cancer Screening
Other
Companies Profiled:
Qiagen
Roche Diagnostics
Hologic
Abbott Laboratories
BD
Seegene, Inc.
Key Questions Answered
1. How big is the global HPV Testing market?
2. What is the demand of the global HPV Testing market?
3. What is the year over year growth of the global HPV Testing market?
4. What is the total value of the global HPV Testing market?
5. Who are the Major Players in the global HPV Testing market?
6. What are the growth factors driving the market demand?
The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three sub-segments, namely, follow-up testing, co-testing, HPV primary testing.
Global HPV Testing key players include Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD, etc. Global top five players hold a share about 80%.
North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, having a total share about 45 percent.
In terms of product, Co-testing is the largest segment, with a share about 55%. And in terms of application, the largest application is Cervical Cancer Screening, followed by Vaginal Cancer Screening, etc.
This report studies the global HPV Testing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for HPV Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of HPV Testing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global HPV Testing total market, 2021-2032, (USD Million)
Global HPV Testing total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: HPV Testing total market, key domestic companies, and share, (USD Million)
Global HPV Testing revenue by player, revenue and market share 2021-2026, (USD Million)
Global HPV Testing total market by Type, CAGR, 2021-2032, (USD Million)
Global HPV Testing total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global HPV Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD, Seegene, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world HPV Testing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global HPV Testing Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global HPV Testing Market, Segmentation by Type:
HPV Testing
Follow-up HPV Testing
Co-testing
Global HPV Testing Market, Segmentation by Application:
Cervical Cancer Screening
Vaginal Cancer Screening
Other
Companies Profiled:
Qiagen
Roche Diagnostics
Hologic
Abbott Laboratories
BD
Seegene, Inc.
Key Questions Answered
1. How big is the global HPV Testing market?
2. What is the demand of the global HPV Testing market?
3. What is the year over year growth of the global HPV Testing market?
4. What is the total value of the global HPV Testing market?
5. Who are the Major Players in the global HPV Testing market?
6. What are the growth factors driving the market demand?
Table of Contents
101 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World HPV Testing Companies Competitive Analysis
- 4 United States VS China VS Rest of World (by Headquarter Location)
- 5 Market Analysis by Type
- 6 Market Analysis by Application
- 7 Company Profiles
- 8 Industry Chain Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
